Evoke Pharma, Inc. announced that Matthew J. D?Onofrio will be succeeding David A. Gonyer as Chief Executive Officer as of March 31, 2024 upon Mr. Gonyer?s departure for personal reasons. Mr. D?Onofrio currently serves as President and Chief Operating Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.458 USD | +5.05% | -2.24% | -56.39% |
Apr. 24 | Transcript : Evoke Pharma, Inc. - Special Call | |
Mar. 21 | Evoke Pharma, Inc. Announces Board Changes as of March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.39% | 3.88M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- EVOK Stock
- News Evoke Pharma, Inc.
- Evoke Pharma, Inc. Announces Chief Executive Officer Changes as of March 31, 2024